Literature DB >> 11581419

Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.

R B Roden1, P M Day, B K Bronzo, W H Yutzy, Y Yang, D R Lowy, J T Schiller.   

Abstract

Coexpression of bovine papillomavirus L1 with L2 mutants lacking either eight N-terminal or nine C-terminal amino acids that encode positively charged domains resulted in wild-type levels of viral genome encapsidation. Despite wild-type binding to the cell surface, the resulting virions were noninfectious. An L2 mutant encoding a scrambled version of the nine C-terminal residues restored infectivity, in contrast to an L2 mutant encoding a scrambled version of the N-terminal residues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581419      PMCID: PMC114625          DOI: 10.1128/JVI.75.21.10493-10497.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein.

Authors:  X Y Sun; I Frazer; M Müller; L Gissmann; J Zhou
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

2.  Synthesis and assembly of infectious bovine papillomavirus particles in vitro.

Authors:  J Zhou; D J Stenzel; X Y Sun; I H Frazer
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

3.  Papillomavirus capsid binding and uptake by cells from different tissues and species.

Authors:  M Müller; L Gissmann; R J Cristiano; X Y Sun; I H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor.

Authors:  R B Roden; N L Hubbert; R Kirnbauer; F Breitburd; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Interaction of papillomaviruses with the cell surface.

Authors:  R B Roden; R Kirnbauer; A B Jenson; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA.

Authors:  A Nakanishi; J Clever; M Yamada; P P Li; H Kasamatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.

Authors:  J Zhou; X Y Sun; K Louis; I H Frazer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells.

Authors:  C Volpers; F Unckell; P Schirmacher; R E Streeck; M Sapp
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  28 in total

Review 1.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

Review 2.  Human Papillomavirus Biology, Pathogenesis, and Potential for Drug Discovery: A Literature Review for HIV Nurse Clinical Scientists.

Authors:  Tara Walhart
Journal:  J Assoc Nurses AIDS Care       Date:  2015-07-08       Impact factor: 1.354

3.  A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.

Authors:  Nadine Kämper; Patricia M Day; Thorsten Nowak; Hans-Christoph Selinka; Luise Florin; Jan Bolscher; Lydia Hilbig; John T Schiller; Martin Sapp
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  Virus-like particles for the prevention of human papillomavirus-associated malignancies.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Expert Rev Vaccines       Date:  2013-02       Impact factor: 5.217

6.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

7.  Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2.

Authors:  Luise Florin; Katrin A Becker; Carsten Lambert; Thorsten Nowak; Cornelia Sapp; Dennis Strand; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  Role of L2 cysteines in papillomavirus infection and neutralization.

Authors:  Ratish Gambhira; Subhashini Jagu; Balasubramanyam Karanam; Patricia M Day; Richard Roden
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

Review 10.  Mechanisms of cell entry by human papillomaviruses: an overview.

Authors:  Caroline A J Horvath; Gaëlle A V Boulet; Virginie M Renoux; Philippe O Delvenne; John-Paul J Bogers
Journal:  Virol J       Date:  2010-01-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.